Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — CKD‑05 Data

Status: Baseline only

  Baseline only

Most Recent Data:
43.0 percent (2013-16) *

Target:
55.4 percent *

Desired Direction:
Increase desired

Baseline:
43.0 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16  *

Age adjusted to the year 2000 standard population.

Show disparities data *

Show disparities data *
Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment  *  
(percent), 2013-16
Population 2013-16
Total
43.0